Evidence map›Paper›PMID 30627087›Full record

ReviewFrontiers in neural circuits2018

Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness.

Tomas Hökfelt, Swapnali Barde, Zhi-Qing David Xu, Eugenia Kuteeva, Joelle Rüegg, Erwan Le Maitre, Mårten Risling, Jan Kehr, Robert Ihnatko, Elvar Theodorsson and 8 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neural circuits, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Galanin receptor 1 expressing neurons in hippocampal-prefrontal circuitry modulate goal directed attention and impulse control.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Obesity-related RNA mJournal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Epigenetics, Resilience, Protective Factors and Factors Promoting Positive Outcomes: A Scoping Review.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Neuropeptides: The Evergreen Jack-of-All-Trades in Neuronal Circuit Development and Regulation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Spontaneous and evoked angiotensin II sniffer cell activity in the lamina terminalis in vitro.American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Tomas HökfeltDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Swapnali BardeDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Zhi-Qing David XuDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Eugenia KuteevaDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Joelle RüeggDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Erwan Le MaitreDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Mårten RislingDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Jan KehrPronexus Analytical AB, Solna, Sweden.
Robert IhnatkoDepartment of Clinical Chemistry, Linköping University, Linköping, Sweden.
Elvar TheodorssonDepartment of Clinical Chemistry, Linköping University, Linköping, Sweden.
Miklos PalkovitsDepartment of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
William DeakinNeuroscience and Psychiatry Unit, University of Manchester, Manchester, United Kingdom.
Gyorgy BagdyDepartment of Pharmacodynamics, Semmelweis University, Budapest, Hungary.
Gabriella JuhaszNeuroscience and Psychiatry Unit, University of Manchester, Manchester, United Kingdom.
H Josée Prud'hommeDouglas Hospital Research Centre, Verdun, QC, Canada.
Naguib MechawarDouglas Hospital Research Centre, Verdun, QC, Canada.
Rochellys Diaz-HeijtzDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Sven Ove ÖgrenDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SELinköping University · SEUniversity of Manchester · GBDouglas Mental Health University Institute · CAHungarian Academy of Sciences · HUMcGill University · CASemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropeptides are auxiliary messenger molecules that always co-exist in nerve cells with one or more small molecule (classic) neurotransmitters. Neuropeptides act both as transmitters and trophic factors, and play a role particularly when the nervous system is challenged, as by injury, pain or stress. Here neuropeptides and coexistence in mammals are reviewed, but with special focus on the 29/30 amino acid galanin and its three receptors GalR1, -R2 and -R3. In particular, galanin's role as a co-transmitter in both rodent and human noradrenergic locus coeruleus (LC) neurons is addressed. Extensive experimental animal data strongly suggest a role for the galanin system in depression-like behavior. The translational potential of these results was tested by studying the galanin system in

Indexed as

AnimalsHumansLocus CoeruleusMental DisordersNeuropeptidesNeurotransmitter AgentsReceptors, NeurotransmitterNeuropeptidesNeurotransmitter AgentsReceptors, Neurotransmitterallostatic loadepigeneticsgalaninlocus coeruleusmajor depression disorderneuropeptidesresilience

Identifiers

PMID30627087
PMCPMC6309708
OpenAlexW2906160505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.